HeliosX Group

What HeliosX Group does

HeliosX monetizes through direct-to-consumer subscription and recurring service revenue across its five brand portfolio, with patients paying for online consultations, prescription medications, and ongoing treatment plans in dermatology, weight management, men's health, and general primary care. The go-to-market motion is product-led growth via self-serve brand websites, organic search, and Trustpilot-anchored social proof rather than enterprise sales. Geographic coverage spans the UK, Germany, Canada, and the US at the brand level, with broader operational presence in the Netherlands, Estonia, Poland, Portugal, and Spain supporting pharmacy and clinical workforce functions. HeliosX is bootstrapped with no external investment, founder-controlled under Dwayne D'Souza, and led day-to-day by CEO Stu Peak alongside a CFO, COO, CPO, and VP-level leadership team.

Name

HeliosX Group

Legal name

HeliosX (legal entity name not explicitly disclosed on website)

Website

https://heliosx.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

251–500 employees

Short description

HeliosX Group operates a vertically-integrated digital health platform running five consumer brands (MedExpress, Dermatica, ZipHealth, RocketRx, Levity) that deliver telemedicine consultations, prescriptions, and pharmacy services to over 4.25 million patients across the UK, Europe, Canada, and the US.

Ownership category

akta.pro rank

Product category

Digital Health and Telemedicine

NAICS

Offices of Physicians (6211), Pharmacies and Drug Retailers (456110)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Dermatology & Acne Prescribing + Pharmacy Delivery Platforms (HLALAIAK)

akta.pro secondary industries

Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Digital health platform
• Telemedicine services
• Online pharmacy
• Direct-to-consumer healthcare
• Prescription delivery

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Digital health subscription and service revenue: Revenue generated through five consumer-facing digital health brands offering telemedicine consultations, prescription medications, and ongoing treatment plans. Subscription and recurring service model for patient care across dermatology, weight management, men's health, and general healthcare conditions.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels3 records

Core offering

HeliosX provides direct-to-consumer telemedicine consultations and prescription medications across everyday healthcare, dermatology, men's health, and weight management through five consumer brands (MedExpress, Dermatica, ZipHealth, RocketRx, Levity). The platform pairs online clinical consultations with an owned pharmacy network that dispenses and delivers treatments in the UK, Germany, Canada, the US, and additional European markets.

Product overview

HeliosX operates a vertically-integrated digital health platform serving five consumer-facing brands. The company combines digital health technology, clinicians, and pharmacies into one connected model. The five brands—MedExpress (everyday treatment and prescriptions), Dermatica (skincare), ZipHealth, RocketRx (men's health), and Levity (weight management)—share a common operating system, clinical standards, and pharmacy network, while serving different health categories and geographic markets (UK, Germany, Canada, US).

Differentiator

Problem solved

Functional benefit

Brands

• MedExpress: Fast, dependable access to everyday treatment, repeat prescriptions, and pharmacy support. Available in UK, Germany, and Canada.
• Dermatica
• ZipHealth
• RocketRx
• Levity

Products and services

• MedExpress Telemedicine and pharmacy service delivering fast, dependable access to everyday treatment, repeat prescriptions, and pharmacy support for individual consumers. Operates in the United Kingdom, Germany, and Canada.
• Dermatica Dermatology service offering science-led personalised skincare with online consultations and long-term treatment plans. Operates in the United Kingdom and United States.
• ZipHealth Direct-to-consumer digital care service providing dependable care journeys built around speed, clarity, and easy access to treatment for individuals in the United States.
• RocketRx Men's health telemedicine service offering direct, discreet care journeys built around speed, clarity, and confidence for men in the United States.
• Levity Weight management service offering online consultations and personalised guidance for sustainable care, serving consumers in the United States.

Quantifiable outcome

• 4.25M+ patients treated
• +2 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Numan: UK-based DTC telehealth company focused on men's health (hair loss, erectile dysfunction, testosterone) with subscription prescribing and home delivery. Direct competitor to RocketRx in the UK men's health category and shares HeliosX's subscription-first DTC prescription model.
• Zava: European DTC online clinic offering consultations, prescriptions, and medicine delivery across multiple countries (UK, Germany, France, Ireland). Directly comparable to HeliosX's MedExpress and Dermatica in scope, geography, and self-serve telemedicine-plus-delivery approach.
• LloydsPharmacy Online Doctor: UK pharmacy-affiliated online doctor service providing consultations and prescription delivery across a broad range of conditions. Comparable to HeliosX's MedExpress brand in combining online consultations with pharmacy fulfillment for everyday treatments.
• Ro: US-based DTC telehealth platform offering vertically-integrated care across men's health, weight management, fertility, and dermatology with owned pharmacy infrastructure. Closely mirrors HeliosX's multi-brand, condition-specific architecture and direct-to-patient delivery model.
• Hims & Hers Health: US-listed DTC telehealth platform operating a multi-brand, multi-vertical consumer health model (hair, skin, sexual health, weight loss) with vertically-integrated pharmacy operations. Directly comparable to HeliosX in business model, brand portfolio architecture, and target customer, though operating primarily in the US market.

Broad incumbents

• Walgreens Boots Alliance: Global pharmacy and retail health giant with growing telehealth capabilities (via VillageMD) and Boots pharmacy network in the UK. Comparable to HeliosX as a pharmacy-distribution-led healthcare platform, though operating at much larger scale with broader retail exposure.
• CVS Health: US healthcare conglomerate combining pharmacy retail (CVS Pharmacy), pharmacy benefit management (Caremark), and telehealth services (MinuteClinic virtual care). Comparable to HeliosX in combining pharmacy infrastructure with digital care delivery, though vastly broader in scope.

Emerging players

• Second Nature: UK-based digital weight management program combining clinician support, GLP-1 prescribing, and behavioral coaching. Directly comparable to HeliosX's Levity brand in the weight management vertical, with overlapping subscription and prescribing model.
• Allurion: Digital weight management platform combining a gastric balloon program with virtual coaching and clinician support. Comparable to HeliosX's Levity brand in the consumer weight management vertical with a hybrid digital-plus-clinical delivery model.

Regional players

• Push Doctor: UK-focused telemedicine platform providing online GP consultations and prescriptions. Comparable as a UK telemedicine operator serving similar patient segments, though narrower in scope than HeliosX's multi-brand portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/heliosx

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeliosX Group